Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2005
11/17/2005US20050256310 Therapeutic compounds
11/17/2005US20050256174 Raf kinase inhibitors
11/17/2005US20050256171 Pyrrolidine derivatives as tryptase inhibitors
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256161 Melanin concentrating hormone receptor antagonists
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050256019 contacting 2S)-2-aminocarbonyl-2,3-dihydro-1H-pyrrole-1-carboxylic acid, 1-(1,1-dimethylethyl) ester with an enzyme which is a fraction of B lipase from yeast candida antarctica, to catalyze the ammonolysis of above compound in presence of ammonium carbamate and/or ammonia
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005DE20122471U1 New deuterated porphobilinogen derivatives useful as therapeutic agents, in association with photodynamic procedures or gamma radiation, in the treatment of tumors and as diagnostic agents in the diagnosis of tumors
11/17/2005DE102004019472A1 Phenylacetamide Phenylacetamides
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565632A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005CA2565630A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005CA2565544A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005CA2564986A1 Pyrrole or imidazole amides for treating obesity
11/16/2005EP1595866A1 Compound inhibiting dipeptidyl peptidase iv
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594839A2 Methode of manufacturing glimepiride and the respective intermediate
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP1363623B1 Peptide deformylase inhibitors
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005EP1237865B1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
11/16/2005CN1696129A Novel process for the synthesis of carboxylic acid phenylamide
11/16/2005CN1696114A Equipment and method for purifying N-ethane pyrrolidone through fractionating
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227229C Ethylene derivatives and pest controlling agents containing same
11/16/2005CN1227228C Delta 1-pyrrolines used as pesticides
11/16/2005CN1227226C Preparation of Lactams from aliphatic alpha, omega-dinitriles
11/15/2005US6965019 Mono-and bis-hydrazone pigments
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2248802C Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105739A2 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
11/10/2005WO2005105738A2 Salt forms of atorvastatin
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005082849A8 Lactams as conformationally constrained peptidomimetic inhibitors
11/10/2005WO2005064349A3 Detection cartridges, modules, systems and methods
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250811 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/10/2005US20050250769 5-Methyl-1-(tetrahydro-pyran-2-ylmethyl)-2-(4-trifluoromethoxy-phenyl)-1H-imidazole-4-carboxylic acid piperidin-1-ylamide; CB1 receptor modulation; obesity; antidiabetic agents;anxiolytic agents; psychosis; schizophrenia; antidepressants; drug abuse/dependance; multiple sclerosis; headaches; antieleptic
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005DE19622168B4 Verfahren zur Trennung von Wertstoffen A process for the separation of valuable materials
11/10/2005CA2649054A1 Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2562160A1 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1592772A2 5ht7 antagonists and inverse agonists
11/09/2005EP1592719A1 Conjugation reactions
11/09/2005EP1592404A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and an excipient like middle chain triglycerides
11/09/2005EP1252166B1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
11/09/2005EP1240139B1 Method for producing n-alkenyl amides
11/09/2005EP1179341B1 Remedies or preventives for diseases in association with chemokines
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1693303A Novel tech. for synthesizing 9-fluorenyl methoxycarbonyl succinic imine
11/09/2005CN1226265C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6963001 Mixtures of copolymers comprising m-phenoxybenzyl acrylate and tricyclodecanedimethanol diacrylates, and dicumyl peroxide, used as adhesives for joining dies; bonding strength; shrinkage inhibition
11/08/2005US6962994 Beta hydroxy ketone is treated with a trialkylborane or dialkylalkoxyborane or a mixture of a trialkylborane and a dialkylalkoxyborane followed by recovery and reuse of the alkylborane species
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962943 Gabusectin derivatives, processes for preparing them and their use
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005CA2195677C Endothelin antagonists
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103035A1 Modified fischer indole synthesis of eletriptan
11/03/2005WO2005103001A1 Phenyl acetamides
11/03/2005WO2005102997A1 3,4-disubstituted maleimides for use as vascular damaging agents
11/03/2005WO2005102996A2 A process for the preparation of 2,2-disubstituted pyrroles
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245739 UV decomposable molecules and a photopatternable monomolecular film formed therefrom
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245579 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245503 Therapeutic heterocycles
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 404